Strong concordance (97.8%) was observed between tumor BRCA and germline BRCA mutations analyzed by FoundationOne®CDx and BRACAnalysis CDx®, respectively, except for one patient who exhibited a germline BRCA1 mutation but lacked a tumor BRCA mutation. The gene discussed is BRCA1; the disease is neoplasm.